Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangju Capsules
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Administration
- Oral
01
Overview
Xiangju Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is primarily indicated for the treatment of respiratory conditions, specifically acute and chronic sinusitis and rhinitis. The formulation is composed of several herbal extracts, including *Astragalus membranaceus*, *Magnolia biondii*, and *Chrysanthemum indicum*. It functions by exerting anti-inflammatory and immunomodulatory effects, helping to alleviate symptoms such as nasal congestion, discharge, and sinus-related headaches. In TCM theory, it is used to dispel wind, clear heat, and resolve toxins.
- Brand names
- Xiangju Capsules
- Other names
- Xiangju Jiaonang
Beyond the preview
Go deeper on Xiangju Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiangju Capsules.